Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study.
Terry-Lorenzo R, Albrecht D, Crouch S, Wong R, Loewen G, Giri N, Skor H, Lin K, Sandiego CM, Pajonas M, Rabiner EA, Gunn RN, Russell DS, Haubenberger D.
Terry-Lorenzo R, et al. Among authors: lin k.
Neuropsychopharmacology. 2025 Jan 5. doi: 10.1038/s41386-024-02046-3. Online ahead of print.
Neuropsychopharmacology. 2025.
PMID: 39757283